Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Rachel M Glicksman"'
Autor:
Antonio Finelli, Ur Metser, Rachel M Glicksman, John Valliant, Peter W Chung, Neil E Fleshner, Robert G Bristow, David Green, Robert Hamilton, Teodor Stanescu, Douglas Hussey, Charles Catton, Mary Gospodarowicz, Padraig Warde, Andrew Bayley, Stephen Breen, Doug Vines, David A Jaffray, Alejando Berlin
Publikováno v:
BMJ Open, Vol 10, Iss 4 (2020)
Introduction The oligometastatic (OM) disease hypothesis of an intermediate metastatic state with limited distant disease deposits amenable for curative therapies remains debatable. Over a third of prostate cancer (PCa) patients treated with radical
Externí odkaz:
https://doaj.org/article/208540cf508c4ea799a20ebc6dfb9d22
Autor:
David A. Palma, Meredith E. Giuliani, Rohann J. M. Correa, Famke L. Schneiders, Stephen Harrow, Matthias Guckenberger, Tina Zhang, Houda Bahig, Sashendra Senthi, Peter Chung, Robert Olson, Michael Lock, Srinivas Raman, Glenn S. Bauman, Benjamin H. Lok, Joanna M. Laba, Rachel M. Glicksman, Timothy K. Nguyen, Pencilla Lang, Joelle Helou, Christopher D. Goodman, Lucas C. Mendez, Peter S. N. van Rossum, Andrew Warner, Stewart Gaede, Alison L. Allan
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-15 (2024)
Abstract Background Emerging randomized data, mostly from phase II trials, have suggested that patients with oligometastatic cancers may benefit from ablative treatments such as stereotactic ablative radiotherapy (SABR). However, phase III data testi
Externí odkaz:
https://doaj.org/article/2b8baa340960407cab86422d2a88489d
Autor:
Rachel M. Glicksman, Andrew Loblaw, Gerard Morton, Danny Vesprini, Ewa Szumacher, Hans T. Chung, William Chu, Stanley K. Liu, Chia-Lin Tseng, Melanie Davidson, Andrea Deabreu, Alexandre Mamedov, Liying Zhang, Patrick Cheung
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 49, Iss , Pp 100843- (2024)
Background and purpose: Data is needed regarding the use of ultrahypofractionated radiotherapy (UHRT) in the context of prostate cancer elective nodal irradiation (ENI), and how this compares to conventionally fractionated radiotherapy (CFRT) ENI wit
Externí odkaz:
https://doaj.org/article/51b8d796a410414e9346719ea6b1cc28
Autor:
Amanda Moreira, Winnie Li, Alejandro Berlin, Cathy Carpino-Rocca, Peter Chung, Leigh Conroy, Jennifer Dang, Laura A. Dawson, Rachel M. Glicksman, Ali Hosni, Harald Keller, Vickie Kong, Patricia Lindsay, Andrea Shessel, Teo Stanescu, Edward Taylor, Jeff Winter, Michael Yan, Daniel Letourneau, Michael Milosevic, Michael Velec
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 29, Iss , Pp 100240- (2024)
Purpose: An integrated magnetic resonance scanner and linear accelerator (MR-linac) was implemented with daily online adaptive radiation therapy (ART). This study evaluated patient-reported experiences with their overall hospital care as well as trea
Externí odkaz:
https://doaj.org/article/e99eb247f3a7441bb24db0648df807f0
Autor:
Rachel M. Glicksman, Vanessa Murad, Anna T. Santiago, Zhihui Liu, Matthew Ramotar, Ur Metser, Alejandro Berlin
Publikováno v:
European Urology Open Science, Vol 52, Iss , Pp 79-84 (2023)
We conducted and previously published a phase 2 trial of metastasis-directed therapy (MDT) in men with recurrence of prostate cancer at a low prostate-specific antigen level following radical prostatectomy and postoperative radiotherapy. All patients
Externí odkaz:
https://doaj.org/article/2102b436229140d8b66152b465147c04
Autor:
Peter J. Gariscsak, Lynn Anson-Cartwright, Eshetu G. Atenafu, Di Maria Jiang, Peter Chung, Philippe Bedard, Padraig Warde, Martin O'Malley, Joan Sweet, Rachel M. Glicksman, Robert J. Hamilton
Publikováno v:
European Urology Open Science, Vol 40, Iss , Pp 46-53 (2022)
Background: We have recommended active surveillance as the preferred management option for clinical stage I (CSI) testicular germ cell tumors (GCTs) since 1980. Over time, the recommended intensity of surveillance has decreased; however, the impact o
Externí odkaz:
https://doaj.org/article/700c690bc6394c308e5d80b0b211d708
Autor:
Rachel M. Glicksman, MD, MSc, Audrey Wong, BSc, MPH, Jonathan Wang, BASc, MASc, Lisa Favell, BA, MBA, Garth Matheson, BComm, MBA, Michael Brundage, MD, FRCPC, Julie Renaud, MRT(T), Kyle Malkoske, PhD, Joanne MacPhail, Derek Finnerty, BA, Sophie Foxcroft, MRT(T), MHSc, Eric Gutierrez, MRT(T), CMD, Padraig Warde, MBChB BAO, FRCPC
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 3, Pp 318-324 (2020)
Purpose: Ontario Health (Cancer Care Ontario), formerly known as CCO, is the provincial governmental agency in Ontario, Canada responsible for developing radiation therapy-specific capital investment strategies, updated every 5 years, to ensure equit
Externí odkaz:
https://doaj.org/article/070535140f5b46b7b55b4cccf613cb1c
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 11, Iss , Pp 22-25 (2019)
Background: The risk of gastrointestinal (GI) toxicity may limit the use of curative-intent radical radiotherapy (RT) for prostate cancer (PCa) in circumstances where morbidity of treatment may exceed an acceptable threshold. Rectal spacers are used
Externí odkaz:
https://doaj.org/article/1000d4bf726d473f85ee539bd5a64a48
Autor:
Rachel M. Glicksman, Matthew Ramotar, Ur Metser, Peter W. Chung, Zhihui Liu, Douglass Vines, Antonio Finelli, Robert Hamilton, Neil E. Fleshner, Nathan Perlis, Alexandre R. Zlotta, Andrew Bayley, Joelle Helou, Srinivas Raman, Girish Kulkarni, Charles Catton, Tony Lam, Rosanna Chan, Padraig Warde, Mary Gospodarowicz, David A. Jaffray, Alejandro Berlin
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:693-704
Publikováno v:
European Urology Focus.